Tian Tan Bioscience (600161.SH) released its performance for the first half of the year, with a net profit attributable to the parent company of 633 million yuan, a year-on-year decrease of 12.88%.

date
21/08/2025
Wisdom Finance News App, Tiantan Bio (600161.SH) released its semi-annual report for 2025. During the reporting period, the company achieved operating income of 3.11 billion yuan, a year-on-year increase of 9.47%. The net profit attributable to the shareholders of the listed company was 633 million yuan, a year-on-year decrease of 12.88%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 618 million yuan, a year-on-year decrease of 14.54%. Basic earnings per share were 0.32 yuan.